It was great to meet with valued editorial board member Murat Emre (Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey), who shared his expert insight of dementia in Parkinson’s disease, covering prevalence, risk factors, diagnosis and treatment.
Questions
1. What proportion of patients with Parkinson’s disease will go on to develop dementia (PDD)? (0:05)
2. What are some of the most typical symptoms? (0:45)
3. Many risk factors have been described for PDD, please could you outline some of the key environmental and genetic risk factors? (1:41)
4. Clinically, how do you diagnose PDD and exclude confounding factors and other explanations for cognitive impairment? (2:54)
5. Please describe how you manage patients with PDD. (4:30)
6. What unmet treatment needs are there for patients with PDD? (6:07)
Speaker disclosure: Murat Emre has nothing relevant to disclose in relation to this video interview.
Filmed at the International Congress of Parkinson’s Disease and Movement Disorders (MDS), Nice, France, September 2019.
